DrWeerachai Jaratlerdsiri

In 2014, I completed PhD in Comparative Genomics from the University of Sydney, characterizing Major Histocompatibility Complex (MHC) using next-generation sequencing technology. Appointed as Postdoctoral Fellow of Australian Prostate Cancer Research Centre, I worked as Bioinformatician in the Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney. I have almost a decade of experience in genomic technologies, population genomics and prostate cancer genomics under Professor Hayes, publishing key cancer genomics findings of ethnic disparity in underrepresented populations, awarding with the best early-career presentation at the Australasian Genomic Technologies Association Conference and with high-impact research from the University of New South Wales. The research continues focusing on genomics technology and its "Big Data" that enable uncovering the role of genetic and environmental factors on human evolution and adaptation to disease, especially prostate cancer. Supported by government-funded collaborations through the US Department of Defence Prostate Cancer Research Programs, Dr Jaratlerdsiri, as Co-Investigator, leads technological development in genomics and data science while working with the team's environment across Australia, South Africa, the UK, and US. Dr Jaratlerdsiri has recently been promoted to a senior role in bioinformatics at the Charles Perkins Centre, Faculty of Medicine & Health, University of Sydney, leading whole genome sequencing interrogation for Southern African Prostate Cancer Study (SAPCS) and Ancestry & Health Genomics Laboratory, whereby prostate cancer health disparity has been examined; also, I maintain the global impact of the research through the lab's membership in Steering Committee of ICGC Pan-Prostate Cancer group (PPCG) that aspires to harmonise whole genome DNA sequence data generated around the world from over 2,000 men from different clinical categories and ethnicities.